Tony Butler
Stock Analyst at Rodman & Renshaw
(0.75)
# 3,961
Out of 4,984 analysts
105
Total ratings
32.35%
Success rate
-13.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $11.59 | +115.70% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.43 | +352.67% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.96 | +818.37% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.08 | +621.15% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.31 | +2,456.73% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.49 | +3,152.69% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.08 | +12,276.24% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $0.95 | +952.63% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $59.07 | +26.97% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $68.18 | -48.66% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $0.79 | +7,502.64% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.36 | +855.88% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $6.92 | +622.54% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.13 | +1,227.43% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.68 | +3,591.67% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.21 | +578.73% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.83 | +13.25% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.20 | +431.25% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.55 | +3,548.35% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.71 | +950.79% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.00 | +11,900.00% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.62 | +861.69% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.31 | +8,252.67% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.51 | -63.70% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.10 | +383.87% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $0.95 | +952.30% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.51 | +327.35% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $12.41 | +786.38% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $5.55 | +17,197.30% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $11.59
Upside: +115.70%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.43
Upside: +352.67%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.96
Upside: +818.37%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.08
Upside: +621.15%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.31
Upside: +2,456.73%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.49
Upside: +3,152.69%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.08
Upside: +12,276.24%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $0.95
Upside: +952.63%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $59.07
Upside: +26.97%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $68.18
Upside: -48.66%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.79
Upside: +7,502.64%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.36
Upside: +855.88%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $6.92
Upside: +622.54%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.13
Upside: +1,227.43%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.68
Upside: +3,591.67%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $2.21
Upside: +578.73%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $8.83
Upside: +13.25%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.20
Upside: +431.25%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.55
Upside: +3,548.35%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $5.71
Upside: +950.79%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.00
Upside: +11,900.00%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.62
Upside: +861.69%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.31
Upside: +8,252.67%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.51
Upside: -63.70%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.10
Upside: +383.87%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $0.95
Upside: +952.30%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $3.51
Upside: +327.35%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $12.41
Upside: +786.38%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $5.55
Upside: +17,197.30%